Skip to main content

Advertisement

SpringerLink
Log in

The pathology of ductal-type pancreatic carcinomas and pancreatic intraepithelial neoplasia: Insights for clinicians

  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

Abstract

The phenotypic classification of pancreatic neoplasms is based on their cellular lineage. Thus, tumors with a ductal, acinar, and endocrine phenotype can be distinguished. Most pancreatic neoplasms show a ductal phenotype and can be classified as ductal adenocarcinomas. Less common tumors with a ductal phenotype are the variants of ductal adenocarcinoma, intraductal papillary mucinous neoplasm (including colloid carcinoma), mucinous cystic neoplasm, medullary carcinoma, and other rare tumors. Ductal adenocarcinomas most likely develop from ductal proliferative lesions arising in the pancreatic duct system. A recently adopted classification system for these lesions distinguishes between three grades of pancreatic intraepithelial neoplasia (PanIN). Molecular studies have revealed that PanIN-2 and PanIN-3 lesions represent a distinct step toward invasive carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Klöppel G, Hruban RH, Longnecker DS, et al.: Ductal adenocarcinoma of the pancreas. In Pathology and Genetics of Tumours of the Digestive System: WHO Classification of Tumours. Edited by Hamilton SR, Aaltonen LA. Lyon, France: IARC Press; 2000:221–230.

    Google Scholar 

  2. Hruban RH, Iacobuzio-Donahue C, Wilentz RE, et al.: Molecular pathology of pancreatic cancer. Cancer J 2001, 7:251–258.

    PubMed  CAS  Google Scholar 

  3. Moore PS, Beghelli S, Scarpa A: Genetic profile of pancreatic tumours. Histopathology 2002, 41(Suppl 2):277–281.

    Google Scholar 

  4. Lüttges J, Galehdari H, Bröcker V, et al.: Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis. Am J Pathol 2001, 158:1677–1683. This study showed an accumulation of genetic alterations with increasing PanIN grade. Moreover, the data indicate that allelic loss is the first hit in the biallelic inactivation of the p53 and DPC4 tumor suppressor genes. Taken together, the data support a tumor progression model for PDAC.

    PubMed  Google Scholar 

  5. Hruban RH, Adsay NV, Albores-Saavedra J, et al.: Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 2001, 25:579–586. This paper presents the PanIN classification, which standardizes terms to cover the various changes in the pancreatic duct system that seem to be relevant to the development of PDAC.

    Article  PubMed  CAS  Google Scholar 

  6. Hruban RH, Wilentz RE, Kern SE: Genetic progression in the pancreatic ducts. Am J Pathol 2000, 156:1821–1825.

    PubMed  CAS  Google Scholar 

  7. Lüttges J, Klöppel G: Differentiating pancreatic tumours by their mucin expression. Histopathology 2002, 41(Suppl. 2):267–294.

    Google Scholar 

  8. Hiyama E, Kodama T, Shinbara K, et al.: Telomerase activity is detected in pancreatic cancer but not in benign tumors. Cancer Res 1997, 57:326–331.

    PubMed  CAS  Google Scholar 

  9. Hahn SA, Greenhalf B, Ellis I, et al.: BRCA2 germline mutations in familial pancreatic carcinoma. J Natl Cancer Inst 2003, 95:214–221.

    Article  PubMed  CAS  Google Scholar 

  10. Solcia E, Capella C, Klöppel G: Tumors of the pancreas. In AFIP Atlas of Tumor Pathology, third series, fascicle 20. Washington, DC: Armed Forces Institute of Pathology; 1997.

    Google Scholar 

  11. Gocke CD, Dabbs DJ, Benko FA, Silverman JF: KRAS oncogene mutations suggest a common histogenetic origin for pleomorphic giant cell tumor of the pancreas, osteoclastoma of the pancreas, and pancreatic duct adenocarcinoma. Hum Pathol 1997, 28:80–83.

    Article  PubMed  CAS  Google Scholar 

  12. Molberg KH, Heffess C, Delgado R, Albores-Saavedra J: Undifferentiated carcinoma with osteoclast-like giant cells of the pancreas and periampullary region. Cancer 1998, 82:1279–1287.

    Article  PubMed  CAS  Google Scholar 

  13. Hoorens A, Prenzel K, Lemoine NR, Klöppel G: Undifferentiated carcinoma of the pancreas: analysis of intermediate filament profile and Ki-ras mutations provides evidence of a ductal origin. J Pathol 1998, 185:53–60.

    Article  PubMed  CAS  Google Scholar 

  14. Imai Y, Morishita S, Ikeda Y, et al.: Immunohistochemical and molecular analysis of giant cell carcinoma of the pancreas: a report of three cases. Pancreas 1999, 18:308–315.

    Article  PubMed  CAS  Google Scholar 

  15. Zamboni G, Klöppel G, Hruban RH, et al.: Mucinous cystic neoplasms of the pancreas. In Pathology and Genetics of Tumours of the Digestive System: WHO Classification of Tumours. Edited by Hamilton SR, Aaltonen LA. Lyon, France: IARC Press; 2000:234–236.

    Google Scholar 

  16. Azar C, Van de Stadt J, Rickaert F, et al.: Intraductal papillary mucinous tumours of the pancreas: clinical and therapeutic issues in 32 patients. Gut 1996, 39:457–464.

    PubMed  CAS  Google Scholar 

  17. Adsay NV, Longnecker DS, Klimstra DS: Pancreatic tumors with cystic dilatation of the ducts: intraductal papillary mucinous neoplasms and intraductal oncocytic papillary neoplasms. Semin Diagn Pathol 2000, 17:16–30.

    PubMed  CAS  Google Scholar 

  18. Chari ST, Yadav D, Smyrk TC, et al.: Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology 2002, 123:1500–1507.

    Article  PubMed  Google Scholar 

  19. Terris B, Ponsot T, Paye F, et al.: Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct. Am J Surg Pathol 2000, 24:1372–1377.

    Article  PubMed  CAS  Google Scholar 

  20. Klöppel G: Pancreatic, non-endocrine tumours. In Pancreatic pathology. Edited by Klöppel G, Heitz PU. Edinburgh, UK: Churchill Livingstone; 1984:79–113.

    Google Scholar 

  21. Sugiyama M, Atomi Y: Extrapancreatic neoplasms occur with unusual frequency in patients with intraductal papillary mucinous tumors of the pancreas. Am J Gastroenterol 1999, 94:470–473.

    Article  PubMed  CAS  Google Scholar 

  22. Sessa F, Solcia E, Capella C, et al.: Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53, and c-erbB-2 abnormalities in 26 patients. Virchows Arch 1994, 425:357–367.

    Article  PubMed  CAS  Google Scholar 

  23. Inoue H, Tsuchida A, Kawasaki Y, et al.: Preoperative diagnosis of intraductal papillary-mucinous tumors of the pancreas with attention to telomerase activity. Cancer 2001, 91:35–41.

    Article  PubMed  CAS  Google Scholar 

  24. Longnecker DS, Adler G, Hruban RH, Klöppel G: Intraductal papillary-mucinous neoplasms of the pancreas. In Pathology and Genetics of Tumours of the Digestive System: WHO Classification of Tumours. Edited by Hamilton SR, Aaltonen LA. Lyon, France: IARC Press; 2000:237–240.

    Google Scholar 

  25. Fujii H, Inagaki M, Kasai S, et al.: Genetic progression and heterogeneity in intraductal papillary-mucinous neoplasms of the pancreas. Am J Pathol 1997, 151:1447–1454.

    PubMed  CAS  Google Scholar 

  26. Iacobuzio-Donahue CA, Klimstra DS, Adsay NV, et al.: Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas. Am J Pathol 2000, 157:755–761.

    PubMed  CAS  Google Scholar 

  27. Lüttges J, Zamboni G, Longnecker D, Klöppel G: The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma. Am J Surg Pathol 2001, 25:942–948. This study shows that IPMNs with a MUC2 phenotype are probably precursors of colloid (mucinous noncystic) carcinoma.

    Article  PubMed  Google Scholar 

  28. Yonezawa S, Taira M, Osako M, et al.: MUC-1 mucin expression in invasive areas of intraductal papillary mucinous tumors of the pancreas. Pathol Int 1998, 48:319–322.

    Article  PubMed  CAS  Google Scholar 

  29. Adsay NV, Adair CF, Heffess CS, Klimstra DS: Intraductal oncocytic papillary neoplasms of the pancreas. Am J Surg Pathol 1996, 20:980–994.

    Article  PubMed  CAS  Google Scholar 

  30. Adsay NV, Pierson C, Sarkar F, et al.: Colloid (mucinous noncystic) carcinoma of the pancreas. Am J Surg Pathol 2001, 25:26–42. This study reveals that colloid (mucinous noncystic) carcinoma of the pancreas is biologically distinct from PDAC and represents an entity of its own.

    Article  PubMed  CAS  Google Scholar 

  31. Seidel G, Zahurak M, Iacobuzio-Donahue CA, et al.: Almost all infiltrating colloid carcinomas of the pancreas and periampullary region arise from in situ papillary neoplasms: a study of 39 cases. Am J Surg Pathol 2002, 26:56–63.

    Article  PubMed  Google Scholar 

  32. Adsay V, Conlon K, Brennan M, Klimstra D: Intraductal papillary-mucinous neoplasms of the pancreas (IPMN): an analysis of in situ and invasive carcinomas associated with 23 cases. Mod Pathol 1997, 10:143A.

    Google Scholar 

  33. Sato N, Rosty C, Jansen M, et al.: STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas. Am J Pathol 2001, 159:2017–2022.

    PubMed  CAS  Google Scholar 

  34. Zamboni G, Scarpa A, Bogina G, et al.: Mucinous cystic tumors of the pancreas: clinicopathological features, prognosis and relationship to other mucinous cystic tumors. Am J Surg Pathol 1999, 23:410–422. This study reveals that recurrence and tumor-related death were features of deeply invasive MCNs only. In addition, it suggests that the similarities in gender, morphology, and stromal luteinization between pancreatic MCN and its ovarian, hepatobiliary, and retroperitoneal counterparts may reflect a common pathway for their development.

    Article  PubMed  CAS  Google Scholar 

  35. Compagno J, Oertel JE: Mucinous cystic neoplasms of the pancreas with overt and latent malignancy (cystadenocarcinoma and cystadenoma): a clinicopathologic study of 41 cases. Am J Clin Pathol 1978, 69:573–580.

    PubMed  CAS  Google Scholar 

  36. Wilentz RE, Albores-Saavedra J, Zahurak M, et al.: Pathologic examination accurately predicts prognosis in mucinous cystic neoplasms of the pancreas. Am J Surg Pathol 1999, 23:1320–1327.

    Article  PubMed  CAS  Google Scholar 

  37. Bartsch D, Barth P, Bastian D, et al.: Higher frequency of DPC4/Smad4 alterations in pancreatic cancer cell lines than in primary pancreatic adenocarcinomas. Cancer Lett 1999, 139:43–49.

    Article  PubMed  CAS  Google Scholar 

  38. Iacobuzio-Donahue CA, Wilentz RE, Argani P, et al.: Dpc4 protein in mucinous cystic neoplasms of the pancreas.: frequent loss of expression in invasive carcinomas suggests a role in genetic progression. Am J Surg Pathol 2000, 24:1544–1548.

    Article  PubMed  CAS  Google Scholar 

  39. Goggins M, Offerhaus GJ, Hilgers W, et al.: Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology: poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+. Am J Pathol 1998, 152:1501–1507. In this study a new tumor type of the pancreas is described.

    PubMed  CAS  Google Scholar 

  40. Wilentz RE, Goggins M, Redston M, et al.: Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: a newly described and characterized entity. Am J Pathol 2000, 156:1641–1651.

    PubMed  CAS  Google Scholar 

  41. Lowenfels AB, Maisonneuve P, DiMagno EP, et al.: Hereditary pancreatitis and the risk of pancreatic cancer. J Natl Cancer Inst 1997, 89:442–446.

    Article  PubMed  CAS  Google Scholar 

  42. Lynch HT, Smyrk T, Kern SE, et al.: Familial pancreatic cancer: a review. Semin Oncol 1996, 23:251–275.

    PubMed  CAS  Google Scholar 

  43. Lüttges J, Vogel I, Menke MAOH, et al.: Clear cell carcinoma of the pancreas: an adenocarcinoma with ductal phenotype. Histopathology 1998, 32:444–448.

    Article  PubMed  Google Scholar 

  44. Adsay V, Logani S, Sarkar F, et al.: Foamy gland pattern of pancreatic ductal adenocarcinoma: a deceptively benign-appearing variant. Am J Surg Pathol 2000, 24:493–504.

    Article  PubMed  CAS  Google Scholar 

  45. Ohike N, Jürgensen A, Pipeleers-Marichal M, Klöppel G: Mixed ductal-endocrine carcinomas of the pancreas and ductal adenocarcinomas with scattered endocrine cells: characterization of the endocrine cells. Virchows Arch 2003, 442:258–265.

    PubMed  CAS  Google Scholar 

  46. Klöppel G: Mixed exocrine-endocrine tumors of the pancreas. Semin Diagn Pathol 2000, 17:104–108.

    PubMed  Google Scholar 

  47. Pour PM, Weide L, Liu G, et al.: Experimental evidence for the origin of ductal-type adenocarcinoma from the islets of Langerhans. Am J Pathol 1997, 150:2167–2180.

    PubMed  CAS  Google Scholar 

  48. Sommers SC, Murphy SA, Warren S: Pancreatic duct hyperplasia and cancer. Gastroenterology 1954, 27:629–640.

    PubMed  CAS  Google Scholar 

  49. Andea A, Sarkar F, Adsay NV: Clinicopathological correlates of pancreatic intraepithelial neoplasia: a comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarcinoma. Mod Pathol 2003, 16:996–1006.

    Article  PubMed  Google Scholar 

  50. Lüttges J, Reinecke-Lüthge A, Möllmann B, et al.: Duct changes and K-ras mutations in the disease-free pancreas: analysis of type, age relation and spatial distribution. Virchows Arch 1999, 435:461–468.

    Article  PubMed  Google Scholar 

  51. Brat DJ, Lillemoe KD, Yeo CJ, et al.: Progression of pancreatic intraductal neoplasias to infiltrating adenocarcinoma of the pancreas. Am J Surg Pathol 1998, 22:163–169.

    Article  PubMed  CAS  Google Scholar 

  52. Brockie E, Anand A, Albores-Saavedra J: Progression of atypical ductal hyperplasia/carcinoma in situ of the pancreas to invasive adenocarcinoma. Ann Diagn Pathol 1998, 2:286–292.

    Article  PubMed  CAS  Google Scholar 

  53. Meckler KA, Brentnall TA, Haggitt RC, et al.: Familial fibrocystic pancreatic atrophy with endocrine cell hyperplasia and pancreatic carcinoma. Am J Surg Pathol 2001, 25:1047–1053.

    Article  PubMed  CAS  Google Scholar 

  54. Klöppel G, Solcia E, Longnecker DS, et al.: Histological typing of tumours of the exocrine pancreas. In WHO International Histological Classification of Tumours, edn 2. Edited by Klöppel G, Solcia E, Longnecker D, et al.: Berlin: Springer; 1996.

    Google Scholar 

  55. Tabata T, Fujimoro T, Maeda S, et al.: The role of ras mutation in pancreatic cancer, precancerous lesions, and chronic pancreatitis. Int J Pancreatol 1993, 14:237–244.

    PubMed  CAS  Google Scholar 

  56. Motojima K, Urano T, Nagata Y, et al.: Detection of point mutations in the Kirsten-ras oncogene provides evidence for the multicentricity of pancreatic carcinoma. Ann Surg 1993, 217:138–143.

    Article  PubMed  CAS  Google Scholar 

  57. Moskaluk CA, Hruban RH, Kern SE: p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. Cancer Res 1997, 57:2140–2143. This work points to the role of p16 and K-ras gene mutations in the progression model of PDAC.

    PubMed  CAS  Google Scholar 

  58. Matsubayashi H, Watanabe H, Nishikura K, et al.: Determination of pancreatic ductal carcinoma histogenesis by analysis of mucous quality and K-ras mutation. Cancer 1998, 82:651–660.

    Article  PubMed  CAS  Google Scholar 

  59. Lüttges J, Schlehe B, Menke MAOH, et al.: The K-ras mutation pattern in pancreatic ductal adenocarcinoma is usually identical to that in associated normal, hyperplastic and metaplastic duct epithelium. Cancer 1999, 85:1703–1710.

    Article  PubMed  Google Scholar 

  60. Yamano M, Fujii H, Takagaki T, et al.: Genetic progression and divergence in pancreatic carcinoma. Am J Pathol 2000, 156:2123–2133.

    PubMed  CAS  Google Scholar 

  61. Heinmöller E, Dietmaier W, Zirngibl H, et al.: Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma. Am J Pathol 2000, 157:83–92.

    PubMed  Google Scholar 

  62. van Heek NT, Meeker AK, Kern SE, et al.: Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia. Am J Pathol 2002, 161:1541–1547.

    Google Scholar 

  63. Day JD, DiGiuseppe JA, Yeo C, et al.: Immunohistochemical evaluation of HER-2/neu expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms. Hum Pathol 1996, 27:119–124.

    Article  PubMed  CAS  Google Scholar 

  64. Maitra A, Adsay NV, Argani P, et al.: Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray. Mod Pathol 2003, 16:902–912.

    Article  PubMed  Google Scholar 

  65. Goggins M, Hruban RH, Kern SE: BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications. Am J Pathol 2000, 156:1767–1771.

    PubMed  CAS  Google Scholar 

  66. Maass N, Hojo T, Ueding M, et al.: Expression of the tumor suppressor gene maspin in human pancreatic cancers. Clin Cancer Res 2001, 7:812–817.

    PubMed  CAS  Google Scholar 

  67. Michl P, Buchholz M, Rolke M, et al.: Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin. Gastroenterology 2001, 121:684.

    Article  Google Scholar 

  68. Iacobuzio-Donahue C, Maitra A, Olsen M, et al.: Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am J Pathol 2003, 162:1151–1162.

    PubMed  CAS  Google Scholar 

  69. Grützmann R, Foerder M, Alldinger I, et al.: Gene expression profiles of microdissected pancreatic ductal adenocarcinoma. Virchows Arch 2003, DOI 10.1007/s00428-003-0884-1.

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, University of Kiel, Michaelisstr. 11, 24105, Kiel, Germany

    Günter Klöppel MD & Jutta Lüttges MD

Authors
  1. Günter Klöppel MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jutta Lüttges MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Klöppel, G., Lüttges, J. The pathology of ductal-type pancreatic carcinomas and pancreatic intraepithelial neoplasia: Insights for clinicians. Curr Gastroenterol Rep 6, 111–118 (2004). https://doi.org/10.1007/s11894-004-0037-y

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11894-004-0037-y

Keywords

Search

Navigation